Total Payments
$16,415
2024 Payments
$798.37
Companies
50
Transactions
358
Medicare Patients
4,358
Medicare Billing
$680,556
Payment Breakdown by Category
Food & Beverage$10,841 (66.0%)
Travel$5,521 (33.6%)
Education$52.16 (0.3%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,841 | 340 | 66.0% |
| Travel and Lodging | $5,521 | 15 | 33.6% |
| Education | $52.16 | 3 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Nuvectra Corporation | $3,659 | 12 | $0 (2018) |
| Nevro Corp. | $3,412 | 30 | $0 (2022) |
| Medtronic USA, Inc. | $2,162 | 80 | $0 (2020) |
| SI-BONE, INC. | $1,419 | 22 | $0 (2021) |
| Abbott Laboratories | $1,000 | 14 | $0 (2022) |
| Boston Scientific Corporation | $804.03 | 23 | $0 (2024) |
| Vertiflex, Inc. | $606.30 | 14 | $0 (2019) |
| Collegium Pharmaceutical, Inc. | $401.87 | 27 | $0 (2023) |
| Medtronic, Inc. | $387.49 | 4 | $0 (2024) |
| Stimwave Technologies Incorporated | $289.87 | 8 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $798.37 | 18 | Medtronic, Inc. ($312.49) |
| 2023 | $136.74 | 5 | Medtronic, Inc. ($75.00) |
| 2022 | $989.97 | 16 | Nevro Corp. ($482.35) |
| 2021 | $707.29 | 27 | Nevro Corp. ($166.86) |
| 2020 | $467.72 | 15 | Nevro Corp. ($206.52) |
| 2019 | $2,202 | 65 | Abbott Laboratories ($886.92) |
| 2018 | $7,818 | 100 | Nuvectra Corporation ($3,347) |
| 2017 | $3,296 | 112 | Medtronic USA, Inc. ($1,092) |
All Payment Transactions
358 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/06/2024 | VERTEX PHARMACEUTICALS INCORPORATED | — | Food and Beverage | In-kind items and services | $31.17 | General |
| 11/11/2024 | Stryker Corporation | MILD DEVICE KIT (Device) | Food and Beverage | In-kind items and services | $150.00 | General |
| Category: INSTRUMENTS | ||||||
| 11/08/2024 | VERTEX PHARMACEUTICALS INCORPORATED | — | Food and Beverage | In-kind items and services | $31.95 | General |
| 10/24/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $124.64 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 10/24/2024 | Curonix LLC | PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A (Device) | Food and Beverage | In-kind items and services | $16.85 | General |
| Category: PAIN MANAGEMENT | ||||||
| 10/17/2024 | Forte Bio-Pharma LLC | NALOCET (Drug), PROLATE, PROLATE | Food and Beverage | In-kind items and services | $17.69 | General |
| Category: PAIN | ||||||
| 09/23/2024 | Forte Bio-Pharma LLC | PROLATE (Drug), NALOCET, PROLATE | Food and Beverage | In-kind items and services | $16.47 | General |
| Category: PAIN | ||||||
| 07/25/2024 | Curonix LLC | PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A (Device) | Food and Beverage | In-kind items and services | $19.30 | General |
| Category: PAIN MANAGEMENT | ||||||
| 06/21/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $56.77 | General |
| 06/11/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $22.77 | General |
| Category: Gastroenterology | ||||||
| 06/04/2024 | Forte Bio-Pharma LLC | NALOCET (Drug), PROLATE, PROLATE | Food and Beverage | In-kind items and services | $19.16 | General |
| Category: PAIN | ||||||
| 05/07/2024 | Forte Bio-Pharma LLC | NALOCET (Drug), PROLATE, PROLATE | Food and Beverage | In-kind items and services | $26.65 | General |
| Category: PAIN | ||||||
| 05/03/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $12.27 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 04/25/2024 | Forte Bio-Pharma LLC | NALOCET (Drug), PROLATE, PROLATE | Food and Beverage | In-kind items and services | $20.05 | General |
| Category: PAIN | ||||||
| 04/20/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $175.58 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 04/20/2024 | Curonix LLC | PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A (Device) | Food and Beverage | In-kind items and services | $24.44 | General |
| Category: PAIN MANAGEMENT | ||||||
| 04/17/2024 | Curonix LLC | PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A (Device) | Food and Beverage | In-kind items and services | $14.17 | General |
| Category: PAIN MANAGEMENT | ||||||
| 02/26/2024 | Boston Scientific Corporation | Intracept (Device) | Food and Beverage | Cash or cash equivalent | $18.44 | General |
| Category: Pain | ||||||
| 12/21/2023 | Relievant Medsystems, Inc. | Intracept (Device), Intracept, Intracept | Food and Beverage | Cash or cash equivalent | $8.91 | General |
| Category: Pain | ||||||
| 12/14/2023 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $75.00 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 12/13/2023 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $16.74 | General |
| Category: Opioid Analgesic | ||||||
| 10/18/2023 | Masimo Corporation | Patient SafetyNet System (Device) | Food and Beverage | In-kind items and services | $18.74 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/06/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $17.35 | General |
| Category: Gastroenterology | ||||||
| 11/03/2022 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $22.94 | General |
| Category: Opioid Analgesic | ||||||
| 06/20/2022 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $12.52 | General |
| Category: Opioid Analgesic | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 563 | 637 | $229,385 | $56,477 |
| 2022 | 17 | 950 | 1,752 | $676,524 | $166,384 |
| 2021 | 26 | 1,577 | 2,732 | $1.3M | $266,692 |
| 2020 | 25 | 1,268 | 2,339 | $931,101 | $191,002 |
Total Patients
4,358
Total Services
7,460
Medicare Billing
$680,556
Procedure Codes
83
All Medicare Procedures & Services
83 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 156 | 193 | $62,339 | $18,401 | 29.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 149 | 167 | $46,760 | $11,282 | 24.1% |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2023 | 34 | 34 | $17,000 | $5,218 | 30.7% |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2023 | 24 | 24 | $14,400 | $4,674 | 32.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 32 | 32 | $15,904 | $3,749 | 23.6% |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2023 | 31 | 31 | $10,850 | $3,476 | 32.0% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Facility | 2023 | 25 | 27 | $15,012 | $2,655 | 17.7% |
| 64494 | Injection of lower or sacral spine facet joint using imaging guidance, second level | Facility | 2023 | 25 | 27 | $8,235 | $1,512 | 18.4% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Facility | 2023 | 14 | 14 | $12,518 | $1,284 | 10.3% |
| 27096 | Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | Facility | 2023 | 14 | 15 | $7,442 | $1,281 | 17.2% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 13 | 22 | $4,126 | $1,074 | 26.0% |
| 62323 | Injection of substance into lower spine canal using imaging guidance | Facility | 2023 | 12 | 12 | $8,340 | $882.56 | 10.6% |
| 20610 | Aspiration and/or injection of fluid from large joint | Facility | 2023 | 11 | 14 | $2,562 | $570.68 | 22.3% |
| 77002 | Fluoroscopic guidance for needle placement | Facility | 2023 | 12 | 14 | $3,402 | $282.01 | 8.3% |
| 80305 | Testing for presence of drug, read by direct observation | Office | 2023 | 11 | 11 | $495.00 | $135.85 | 27.4% |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2022 | 94 | 207 | $123,372 | $40,696 | 33.0% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2022 | 170 | 414 | $77,933 | $25,347 | 32.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 151 | 246 | $97,216 | $22,286 | 22.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 160 | 256 | $73,006 | $16,881 | 23.1% |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2022 | 55 | 96 | $34,637 | $10,540 | 30.4% |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2022 | 31 | 63 | $29,610 | $9,770 | 33.0% |
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | Facility | 2022 | 42 | 54 | $38,770 | $7,913 | 20.4% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Facility | 2022 | 30 | 51 | $38,446 | $5,507 | 14.3% |
| 27096 | Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | Facility | 2022 | 47 | 72 | $37,553 | $5,307 | 14.1% |
| 64625 | Destruction of nerves supplying joint between spine and pelvis using imaging guidance | Facility | 2022 | 25 | 31 | $20,362 | $4,624 | 22.7% |
About Dr. Ramon Espinal, MD
Dr. Ramon Espinal, MD is a Interventional Pain Medicine healthcare provider based in Covington, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/18/2005. The National Provider Identifier (NPI) number assigned to this provider is 1851390363.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ramon Espinal, MD has received a total of $16,415 in payments from pharmaceutical and medical device companies, with $798.37 received in 2024. These payments were reported across 358 transactions from 50 companies. The most common payment nature is "Food and Beverage" ($10,841).
As a Medicare-enrolled provider, Espinal has provided services to 4,358 Medicare beneficiaries, totaling 7,460 services with total Medicare billing of $680,556. Data is available for 4 years (2020–2023), covering 83 distinct procedure/service records.
Ad
Practice Information
- Specialty Interventional Pain Medicine
- Other Specialties Pain Medicine
- Location Covington, GA
- Active Since 07/18/2005
- Last Updated 05/03/2021
- Taxonomy Code 208VP0014X
- Entity Type Individual
- NPI Number 1851390363
Products in Payments
- Algovita (Device) $3,659
- Senza Spinal Cord Stimulation System (Device) $2,762
- RESTORE (Device) $1,683
- iFuse Implant (Device) $1,280
- Proclaim Family of SCS IPGs (Device) $957.79
- Omnia (Device) $649.21
- Superion ISS (Device) $606.30
- INTELLIS ADAPTIVESTIM (Device) $387.49
- MYSTIM (Device) $259.44
- XTAMPZA (Drug) $249.00
- RELISTOR (Drug) $223.56
- StimQ Receiver Stimulator Kit Channel A US w/Receiver (Device) $216.55
- GENERAL - PAIN MANAGEMENT (Device) $157.91
- SYNCHROMED (Device) $150.94
- MILD DEVICE KIT (Device) $150.00
- SPECTRA IPG (Device) $138.62
- IFUSE IMPLANT (Device) $138.33
- WaveWriter Alpha Prime 16 (Device) $132.36
- GENERAL PAIN MANAGEMENT (Device) $131.27
- LYRICA (Drug) $113.05
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Interventional Pain Medicine Doctors in Covington
Chad Domangue, Md, MD
Interventional Pain Medicine — Payments: $179,235
Interventional Pain Medicine $179,235
Rhee Miller, Md, MD
Interventional Pain Medicine — Payments: $27,313
Interventional Pain Medicine $27,313
Dr. Richard Robertson, M.d, M.D
Interventional Pain Medicine — Payments: $9,701
Interventional Pain Medicine $9,701
Dr. Allan Parr, M.d, M.D
Interventional Pain Medicine — Payments: $5,094
Interventional Pain Medicine $5,094
Ashna Parti, Do, DO
Interventional Pain Medicine — Payments: $3,797
Interventional Pain Medicine $3,797